These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33720741)
1. Symptomatic hypomagnesemia induced by proton-pump inhibitors (PPIs). A known adverse event that is worth recalling. Keco Huerga A; García de la Borbolla Serres J; Castro Fernández M Rev Esp Enferm Dig; 2021 Oct; 113(10):728-729. PubMed ID: 33720741 [TBL] [Abstract][Full Text] [Related]
2. Proton-pump inhibitors adverse effects: a review of the evidence and position statement by the Sociedad Española de Patología Digestiva. de la Coba Ortiz C; Argüelles Arias F; Martín de Argila de Prados C; Júdez Gutiérrez J; Linares Rodríguez A; Ortega Alonso A; Rodríguez de Santiago E; Rodríguez-Téllez M; Vera Mendoza MI; Aguilera Castro L; Álvarez Sánchez Á; Andrade Bellido RJ; Bao Pérez F; Castro Fernández M; Giganto Tomé F Rev Esp Enferm Dig; 2016 Apr; 108(4):207-24. PubMed ID: 27034082 [TBL] [Abstract][Full Text] [Related]
3. Hypomagnesemia and proton-pump inhibitors. Famularo G; Gasbarrone L; Minisola G Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631 [TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us? Luk CP; Parsons R; Lee YP; Hughes JD Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281 [TBL] [Abstract][Full Text] [Related]
5. The association of proton pump inhibitors and hypomagnesemia in the community setting. Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616 [TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort. Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924 [TBL] [Abstract][Full Text] [Related]
7. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg. Furlanetto TW; Faulhaber GA Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654 [TBL] [Abstract][Full Text] [Related]
8. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study. Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584 [TBL] [Abstract][Full Text] [Related]
9. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. Semb S; Helgstrand F; Hjørne F; Bytzer P World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234 [TBL] [Abstract][Full Text] [Related]
10. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic. Uehara A; Kita Y; Sumi H; Shibagaki Y Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187 [TBL] [Abstract][Full Text] [Related]
11. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia. Chrysant SG; Chrysant GS Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777 [No Abstract] [Full Text] [Related]
12. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV. Sutton SS; Magagnoli J; Cummings T; Hardin JW J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693 [TBL] [Abstract][Full Text] [Related]
13. Hypomagnesemia associated with a proton pump inhibitor. Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510 [TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study. Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254 [TBL] [Abstract][Full Text] [Related]
15. [Severe hypomagnesaemia due to proton pump inhibitor use]. van den Berg S; Scheer MLJ; Holman ND Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626 [TBL] [Abstract][Full Text] [Related]
16. Serum magnesium and proton-pump inhibitors use: a cross-sectional study. Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271 [TBL] [Abstract][Full Text] [Related]
17. Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis. Liao S; Gan L; Mei Z Medicine (Baltimore); 2019 Mar; 98(13):e15011. PubMed ID: 30921222 [TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation and QT prolongation due to proton pump inhibitor-induced hypomagnesemia]. Noirclerc N; Delfanne C; Dompnier A Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):201-203. PubMed ID: 32800318 [TBL] [Abstract][Full Text] [Related]
19. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review. William JH; Danziger J J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556 [TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies. Srinutta T; Chewcharat A; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P Medicine (Baltimore); 2019 Nov; 98(44):e17788. PubMed ID: 31689852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]